Literature DB >> 19034952

Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of Down syndrome.

Pavel V Belichenko1, Alexander M Kleschevnikov, Eliezer Masliah, Chengbiao Wu, Ryoko Takimoto-Kimura, Ahmad Salehi, William C Mobley.   

Abstract

Down syndrome (DS) is a neurological disorder causing impaired learning and memory. Partial trisomy 16 mice (Ts65Dn) are a genetic model for DS. Previously, we demonstrated widespread alterations of pre- and postsynaptic elements and physiological abnormalities in Ts65Dn mice. The average diameter of presynaptic boutons and spines in the neocortex and hippocampus was enlarged. Failed induction of long-term potentiation (LTP) due to excessive inhibition was observed. In this paper we investigate the morphological substrate for excessive inhibition in Ts65Dn. We used electron microscopy (EM) to characterize synapses, confocal microscopy to analyze colocalization of the general marker for synaptic vesicle protein with specific protein markers for inhibitory and excitatory synapses, and densitometry to characterize the distribution of the receptor and several proteins essential for synaptic clustering of neurotransmitter receptors. EM analysis of synapses in the Ts65Dn vs. 2N showed that synaptic opposition lengths were significantly greater for symmetric synapses (approximately 18%), but not for asymmetric ones. Overall, a significant increase in colocalization coefficients of glutamic acid decarboxylase (GAD)65/p38 immunoreactivity (IR) (approximately 27%) and vesicular GABA transporter (VGAT)/p38 IR (approximately 41%) was found, but not in vesicular glutamate transporter 1 (VGLUT1)/p38 IR. A significant overall decrease of IR in the hippocampus of Ts65Dn mice compared with 2N mice for glutamate receptor 2 (GluR2; approximately 13%) and anti-gamma-aminobutyric acid (GABA)(A) receptor beta2/3 subunit (approximately 20%) was also found. The study of proteins essential for synaptic clustering of receptors revealed a significant increase in puncta size for neuroligin 2 (approximately 13%) and GABA(A) receptor-associated protein (GABARAP; approximately 13%), but not for neuroligin 1 and gephyrin. The results demonstrate a significant alteration of inhibitory synapses in the fascia dentata of Ts65Dn mice. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19034952     DOI: 10.1002/cne.21895

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  67 in total

Review 1.  Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders.

Authors:  Sacha B Nelson; Vera Valakh
Journal:  Neuron       Date:  2015-08-19       Impact factor: 17.173

2.  Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome.

Authors:  Alexander M Kleschevnikov; Pavel V Belichenko; Jessica Gall; Lizzy George; Rachel Nosheny; Michael T Maloney; Ahmad Salehi; William C Mobley
Journal:  Neurobiol Dis       Date:  2011-10-17       Impact factor: 5.996

3.  Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome.

Authors:  Verónica Vidal; Susana García-Cerro; Paula Martínez; Andrea Corrales; Sara Lantigua; Rebeca Vidal; Noemí Rueda; Laurence Ozmen; Maria-Clemencia Hernández; Carmen Martínez-Cué
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

Review 4.  Down syndrome: the brain in trisomic mode.

Authors:  Mara Dierssen
Journal:  Nat Rev Neurosci       Date:  2012-12       Impact factor: 34.870

5.  Dentate gyrus mediates cognitive function in the Ts65Dn/DnJ mouse model of Down syndrome.

Authors:  Genevieve K Smith; Raymond P Kesner; Julie R Korenberg
Journal:  Hippocampus       Date:  2013-12-13       Impact factor: 3.899

6.  Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.

Authors:  Melissa J Alldred; Helen M Chao; Sang Han Lee; Judah Beilin; Brian E Powers; Eva Petkova; Barbara J Strupp; Stephen D Ginsberg
Journal:  FASEB J       Date:  2019-06-10       Impact factor: 5.191

7.  Organization of amyloid-beta protein precursor intracellular domain-associated protein-1 in the rat brain.

Authors:  Amanda L Jacob; Bryen A Jordan; Richard J Weinberg
Journal:  J Comp Neurol       Date:  2010-08-15       Impact factor: 3.215

8.  Environmental enrichment rescues postnatal neurogenesis defect in the male and female Ts65Dn mouse model of Down syndrome.

Authors:  Lina Chakrabarti; Joseph Scafidi; Vittorio Gallo; Tarik F Haydar
Journal:  Dev Neurosci       Date:  2011-08-25       Impact factor: 2.984

9.  Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down's syndrome.

Authors:  D Colas; B Chuluun; D Warrier; M Blank; D Z Wetmore; P Buckmaster; C C Garner; H C Heller
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

10.  Increased cortical synaptic activation of TrkB and downstream signaling markers in a mouse model of Down Syndrome.

Authors:  R L Nosheny; P V Belichenko; B L Busse; A M Weissmiller; V Dang; D Das; A Fahimi; A Salehi; S J Smith; W C Mobley
Journal:  Neurobiol Dis       Date:  2015-03-06       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.